AcuSpray vs 76 Fence

The numbers paint a clear picture, but the numbers that matter aren’t the obvious ones. 76 Fence has the head-start on paper: real franchised unit history, a current FDD, and a substantially higher AUV at $1.54M. That revenue ceiling directly translates into a stronger budget signal—an owner doing over $1.5M is a serious operator who can justify software spend, not a startup burning cash on a logo. The TAM is microscopic for both, but 76 Fence at least gives you a live reference account to point to, which collapses the sales cycle from theoretical to tangible.

The terrain is where the tradeoff gets sharp, and it’s a trap. AcuSpray runs an approved-supplier procurement model, which is usually catnip for a vendor because it means you don’t have to fight a corporate gatekeeper. But that advantage evaporates when the brand has zero franchised units and a stale FDD. You’d be selling into a future that doesn’t exist yet. 76 Fence’s franchisor-controlled procurement is objectively harder to penetrate, but the timing dimension overrules it: they’re current, they’re active, and the corporate lock on procurement means if you do close the franchisor, you get a forced-march rollout to every unit that opens, not a polite recommendation.

AcuSpray’s 20% royalty is a glaring red flag, not a feature. That fee structure starves unit-level margins, leaving operators with no dry powder for third-party software unless the franchisor bundles it. Pair that with an overdue filing, and you’re looking at a brand that may not even be actively selling licenses. The only meaningful win for AcuSpray is procurement openness, but that’s a theoretical edge in a deal that has no immediate revenue path. 76 Fence’s combination of live economics and current compliance makes it the only brand here with a beatable door and a check behind it.

Verdict: 76 Fence is the stronger software-sales opportunity because budget and timing outweigh a favorable procurement model locked inside a dead filing.